PIN56 Cost-Effectiveness Model to Evaluate 200-Day vs 100-Day Treatment with Valganciclovir Prophylaxis to Reduce Cytomegalovirus Disease in High-Risk (D+/R-) Kidney Transplant Recipient in Spain | Publicación